(The Center Square) – Medicare Part D sponsors made $587.7 million in ineligible payments to pharmacies for five drugs carrying obsolete prescription-only labeling more than a year after the corresponding brand-name drugs switched to over-the-counter status, a federal watchdog found.
From
To
Independent pharmacy Whitaker Drugs is the Wilcox Area Chamber of Commerce's (WACC) March Business of the Month.Â
FDA commissioner Marty Makary (right) and Sen. Markwayne Mullin (right) listen as Health and Human Services Secretary Robert F. Kennedy Jr. sp…
(The Center Square) – The U.S. Food and Drug Administration plans to require new labels on all opioid pain medications that emphasizes long-te…
WEDNESDAY, June 18, 2025 (HealthDay News) -- On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited r…
WEDNESDAY, June 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapam…
MONDAY, June 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr …